These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10606427)

  • 1. Survival of patients with squamous cell carcinoma of the supraglottic larynx--thirty-five-year experience with radiotherapy.
    Vermund H; Boysen M; Evensen JF; Jacobsen AB; Natvig K; Tausjø J; Wiley AL; Winther F
    Acta Oncol; 1999; 38(7):961-8. PubMed ID: 10606427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
    Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
    Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma of the supraglottic larynx without clinically detectable lymph node metastases: problem of local relapse and influence of overall treatment time.
    Hoekstra CJ; Levendag PC; van Putten WL
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):13-21. PubMed ID: 2298616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exclusive radiotherapy in 250 cases of stage I-II cancers of the supraglottic larynx].
    Glínski B; Reinfuss M; Walasek T; Skolyszewski J
    Bull Cancer Radiother; 1996; 83(3):177-9. PubMed ID: 8977571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy for squamous cell carcinoma of the supraglottic larynx.
    Shimm DS; Coulthard SW
    Am J Clin Oncol; 1989 Feb; 12(1):17-23. PubMed ID: 2912019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T3 supraglottic cancer: treatment results and prognostic factors.
    Woo JS; Baek SK; Kwon SY; Jung KY; Lee J
    Acta Otolaryngol; 2003 Oct; 123(8):980-6. PubMed ID: 14606603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence after different primary treatment for cancer of the supraglottic larynx.
    Vermund H; Boysen M; Evensen JF; Jacobsen AB; Natvig K; Tausjo J; Wiley AL; Winther F
    Acta Oncol; 1998; 37(2):167-73. PubMed ID: 9636011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy.
    Howell-Burke D; Peters LJ; Goepfert H; Oswald MJ
    Arch Otolaryngol Head Neck Surg; 1990 Jul; 116(7):830-5. PubMed ID: 2363922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.
    Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
    Acta Otolaryngol; 2018 Nov; 138(11):1028-1034. PubMed ID: 30735065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study of 213 patients with laryngeal cancer].
    Miyahara H; Yane K; Tsuruta Y; Uemura H
    Nihon Jibiinkoka Gakkai Kaiho; 2002 Jul; 105(7):790-8. PubMed ID: 12174612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
    Furusaka T; Susaki Y; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2013 Jan; 133(1):91-8. PubMed ID: 23106387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
    Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
    Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
    Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
    Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma of the subglottis.
    Garas J; McGuirt WF
    Am J Otolaryngol; 2006; 27(1):1-4. PubMed ID: 16360814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.